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INTRODUCTION
There is an escalating demand for herbal drug therapy, many plant species are being explored and are used in various human cultures around the world for their medicinal properties. [1] These natural drugs help in maintaining the homeostasis. When cells are under stress, they produce free radicals like reactive oxygen species (ROS) and reactive nitrogen species (RNS) that damage the cells in many ways such as lipid peroxidation (LPO), protein denaturation, and DNA damage. [2] Nitric oxide (NO) is an important mediator of many physiological functions and its role in the inflammatory process is gaining recognition. [3] Natural antioxidants have an important role in protecting the cells against damage by ROS/RNS, which can lead to several afflictions such as inflammation [4, 5] and diabetes. [6] Inflammation is one of the first responses to cell and tissue damage inflicted by diverse factors such as infections and chemicals and physical injuries. Inflammation is caused by the release of various inflammatory mediators such as cytokines ([interleukin [IL] 1β, IL6), tumor necrosis factor alpha (TNFα), prostaglandins, bradykinin, histamine, growth factors, neurogenic factors, and followed by central sensitization and hypersensitivity. [7] During such conditions, nonsteroidal antiinflammatory drugs (NSAIDs) are used to alleviate pain and reduce inflammation. [8] However, longterm use of these NSAIDs may lead to certain types of ulcers and other disorders, [9] and hence there is a prompt need to search for an alternative to these synthetic drugs where herbal medicines can be suitable candidates.
Emblica officinalis Gaertn., syn. Phyllanthus emblica L., popularly known as Indian gooseberry, is a small to mediumsized deciduous tree, native to India and the Middle East, belonging to the family Euphorbiaceae. It is commonly known as "Amla" in India and is used in Ayurveda as "rejuvenating herb" since ancient times. [10] E. officinalis extract contains several antioxidants such as emblicanin A and B, gallic acid, ellagic acid, ascorbic acid (AA) (Vitamin C), which are used to treat several medical conditions. [11] showing correlation between in vivo antiinflammatory effects and antioxidant properties for this wonder berry. Hence, the present report emphasizes on in vivo antiinflammatory effectiveness of methanolic extract of Emblica officinalis fruit (MEO) using carrageenaninduced rat paw oedema model and a wide spectrum of in vitro antioxidant studies which includes models like 2,2'azinobis 3ethylbenzthiazoline6sulphonic acid (ABTS+), 1,1diphenyl2picrylhydrazyl (DPPH), molybdenum reduction method, NO determination, and LPO, along with quantitative analysis of potential antioxidant compounds of MEO by high performance liquid chromatography (HPLC).
MATERIALS AND METHODS

Chemicals and reagents
Acetic anhydride, ammonium hydroxide, AA, butylated hydroxytoluene, 2deoxy2ribose, DPPH, ferric chloride, gallic acid, magnesium ribbon, quercetin, sodium nitrite, and trichloroacetic acid were obtained from HiMedia Laboratories, Pvt., Ltd., Mumbai, India. 
Preparation of plant material
Methanolic extract was prepared using 500 g of coarse dried fruit powder, which was extracted in Soxhlet apparatus with 2 l of methanol for 24 h, in a three cycle process. Then, the mixture was filtered, concentrated, and lyophilized (LyoQuest, Telstar, Spain). [13] The MEO was dissolved in doubledistilled water in desired concentrations before analysis.
In vitro assays
ABTS radical cations were produced by mixing ABTS and MEO and incubating the mixture at room temperature for 16 h in dark condition. This was followed by addition of 20 µl of 10 mM phosphate buffer saline (pH 7.4), test solutions of various concentrations, and 230 µl of ABTS radical solution (0.238 mM). [14] The absorbance was measured immediately at 734 nm spectrophotometer (Elico, SL 210). A control reaction was carried out without the test sample. Linear graph of concentration against percentage inhibition was constructed, and IC value was calculated.
Different concentrations of test solution and 50:l of DPPH (0.659 mM) solution was incubated at 25°C for 20 min, after which the absorbance was read at 510 nm using spectrophotometer (Elico, SL 210). [15] A control reaction was carried out without the test sample. Linear graph of concentration against percentage inhibition was constructed, and IC value was calculated. The percentage inhibition was calculated according to the following equation:
where A was the absorbance of the control (blank, without extract), and A was the absorbance in the presence of the extract.
The total antioxidant capacity of MEO was assessed by phosphomolybdenum method. [16] To 0.3 mL of extract solution (1 mg/mL), 3 mL reagent solution (28 mM sodium phosphate, 6 M sulfuric acid and 4 mM ammonium molybdate) was added and incubated at 95°C for 90 min. Then, the absorbance of the solution was measured at 695 nm against blank spectrophotometer (Elico, SL 210). The antioxidant capacity of the extract was evaluated as AA equivalents.
Malondialdehyde (MDA), a marker of LPO was estimated by the method of Okhawa et al. [17] and as modified by Middha et al. [18] using 1,1,3,3tetramethoxy propane as the standard, measured at 532 nm and expressed in nM/mg protein.
Quantitative analysis of antioxidant compounds HPLC (Waters Corporation, Singapore) protocol was followed as per Middha et al. [19] Active constituent in the MEO extract was dissolved in a mixture of methanol and water (6:4 v/v), and identified by comparison of the retention time in chromatogram with standard Vitamin C, gallic acid, rutin, quercetin, and ellagic acid (Sigma Chemical Co., St Louis, USA). Data were analyzed using Empower software (Waters Corporation, Singapore).
In vivo assay
Male Wistar albino rats (140-160 g) and Swiss albino mice (25-30 g) were ordered from Indian Institute of Sciences (Bangalore, India), housed in groups of 4 and given 7 days to acclimate to the housing facility in polypropylene, polycarbonate, and stainless steel cages. Rats were randomly selected and sheltered under standard laboratory conditions of light and dark cycles of 7:00 am to 7:00 pm, temperature of 25°C ± 2°C, lighting of 350 lux, and 68% ± 1% relative humidity and given access to rat maintenance food (Lipton India Ltd., Bangalore, India) and tap water ad libitum. Cages (size 421 mm × 290 mm × 190 mm with a gap of 7 mm between wires) and corn cob bedding were changed every alternate day to ensure that animals are clean and dry as per the National Institutes of Health guidelines.
[20] During housing, animal's health status was monitored twice daily, and no adverse events were detected. The study protocol was approved by Maharani Lakshmi Ammanni College Ethical Committee, clearance from Ethical Committee (1368/ac/10/CPCSEA), Bangalore, India.
Swiss albino mice (25-30 g) of both sexes were divided into six groups of 10 each. Animals were housed 5 per cage and were starved overnight but were given water preceding the experiment. MEO was administered to each group at different dose levels of 0.5, 1.0, 1.5, 2.0, 2.5, and 3.0 g/kg BW/ml. The mice were kept under observation for 24 h, mortality was recorded, and LD (median lethal dose) was determined as per Middha et al. [18] The carrageenaninduced rat paw edema test [21] was used as an experimental model for testing the antiinflammatory activity of MEO. The rats were divided into five groups of six rats each as shown in Table 1 . The investigated MEO, dissolved in dimethyl sulphoxide (DMSO) were administered orally in doses of 200 mg/kg and 400 mg/kg; these doses were selected based on an initial toxicity screening for up to 24 h. Diclofenac (10 mg/kg) (Sigma Chemical Co., St. Louis, USA) dissolved in DMSO, was used as a reference drug. The control animals were given the vehicle (1 ml/kg p.o. DMSO). 1 h after the oral administration of the extracts or diclofenac, carrageenansaline solution (0.5% w/v) and saline were injected in a volume of 0.1 ml into the plantar surface of the right and left hind paw, respectively. Left paw served as the control (noninflamed) paw. The animals were observed for 0 h, 1 h, 2 h, and 4 h; the paw volume was measured using plethysmometer (PanLab, Barcelona, Spain). [21] The anti inflammatory effect was calculated using the equation below:
Antiinflammatory effect (%) = k − e/k × 100 where k is the difference in the paw weight in the control group and e is the difference in the paw weight in the treatment group. 
After euthanization, the carcasses were placed in a nonPVC containing, sealable, and transparent plastic bag and were sent to incinerator. Blood samples were collected by heart puncture method, and serum was separated for biochemical estimations.
The serum concentration of IL1β was measured using a commercial enzymelinked immunosorbent assay (ELISA) kit method (Biosource, San Diego, California) [22] and TNFα was measured with another ELISA kit (Endogen, Woburn, MA, USA). [23] Statistical analysis
All the measurements were repeated six times and expressed as a mean ± standard error of means and Statistically analyzed by two way analysis of variance followed by Tukey's multiple ranges using GraphPad prism (GraphPad, San Diego, CA, USA)
RESULTS
Yield of the extract
The total yield of the extract was found to be 9.8%.
In vitro activity
A dosedependent inhibition of scavenging activity was displayed by MEO to ABTS radical [ Figure 1 ]. The percentage of ABTS scavenging by MEO was found to be at 23.03% and 94.16% at 10 µg/ml and 100 µg/ml, respectively.
MEO showed radical scavenging activity as measured by DPPH, across concentrations ranging from 0.1 to 1.0 µg/ml [ Figure 2] . The values for maximum % inhibition at 0.1-1 mg/ml ranged from 7.33% to 83.33% in MEO, whereas that of standard (AA) was found to be 90%. The high DPPH scavenging activities of the methanolic extract have already been reported by other researchers. [24] IC of MEO was found to be 0.628 µg/ml.
The principle includes the reduction of Mo (VI) to Mo (V) by the extract that contains antioxidant compounds. In this study, MEO was more effective in reduction of Mo (VI) to Mo (V) (142.0 ± 6.09 μg/ml). The reduction of Mo (VI) to Mo (V) by administration of reference chemical, AA (IC 81.3 ± 4.12 μg/ml), suggested the presence of effective antioxidants in MEO.
Decrease in the MDA levels is a good indication of an effective antioxidant. There was a significant dosedependent reduction in MDA levels by MEO. Maximum percentage reduction in MDA levels of 56.54% was observed at 300 μg/ml concentration of MEO.
HPLC method has been reported to be simple, easy to use, and effective enough for the identification and quantification of major phenolic compounds found in aromatic plants, [19, 25] despite the fact that the separation of procyanidins is not satisfactory with these phases. [25] To deduce a better separation of phenolic acids and flavonoids in aromatic plants, we have used Spherisorb C18 stationary phase, which provided a quite fine outcome. After extraction and acid hydrolysis, the content of phenolic substances was determined. Quantification was done via calibration with standards. The amount of phenolic acids such as quercetin (28.00 mg/100 g), rutin (3.89 mg/100 g), βglucogallin (0.146 mg/ml), gallic acid (2.10 mg/100 g), and mucic acid (4.90 mg/100 g) were detected in the analyzed samples [ Figure 3 ]. Quercetin has been reported to be present in a large number of herbals. [19, 26] Rutin in some cases can be hydrolyzed to quercetin (aglycone). This could have happened in our sample of interest. Acute toxicity
Antiinflammatory activity
Effect of methanolic extract of Emblica officinalis on different cytokine levels Thus, hydrolysis was needed for the identification and quantitative determination of phenolic acids. Time of harvest and storing conditions might have an effect on the variations in the phenolic compounds.
Assessment of pharmacological activity (in vivo)
In vivo median lethal dose or LD of the extract was 1125 mg/kg BW. Other parameters such as body weight and survival rate showed no side effects to MEO (data not shown).
Carrageenaninduced paw edema: MEO significantly (P < 0. 01) exhibited anti inflammatory activity in a dosedependent manner at 4 h. The reduction in carrageenaninduced paw edema by high dosage of MEO (HMEO) after 4 h was 72.71% while edema reduction by the standard drug, diclofenac (10 mg/kg) was 61.57% [ Table 1 ]. MEO produced a dosedependent inhibition of paw edema, which was comparable to the effect of known antiinflammatory drug, diclofenac.
Cytokines are small glycoproteins counteracted in response to an antigen and initially defined as a mediator for regulating the innate and adaptive immune reactions. At the time of inflammation, IL1β and TNFα are the two major cytokines, which play a major role in leading mechanisms. [7] The levels of these cytokines should be suppressed to reduce the severity of the inflammatory reaction. Table 2 indicates that inflammatory reaction induced by carrageenan significantly increased the concentration of IL1β and TNFα (P < 0.05). MEO treatment decreased the level of these cytokines significantly as compared to the inflammationinduced group.
DISCUSSION
Quite a lot of present day diseases are due to the shift in the balance of prooxidant and antioxidant homeostasis in the body. [13, 27] Inflammation is the response to injury of cells and body tissues through different factors such as infections and chemicals and mechanical injuries. [22, 28] The pathogenesis of inflammation is brought about by free radicals. [22, 29, 30] Plants have many compounds which show different bioactivities, including antioxidant and antiinflammatory, which are experimented on because of their numerous mechanisms of actions with nontoxic nature. [19] Antioxidants interfere with the oxidative processes by scavenging free radicals and chelating free catalytic metals. [31] There are numerous NSAIDs existing in the market, but these drugs have been shown to have certain side effects that may cause cardiovascular and gastrointestinal disorders; therefore, it is important to endorse the drugs from natural sources. [32] Emblica has been used for the treatment of arthritis and other inflammatory diseases. [32] A wide variety of in vitro methods such as DPPH and ABTS are used to assess radical scavenging ability of certain agents from natural and synthetic sources. DPPH is a stable free radical, and its activity is based on its ability to decolorize from deep purple color at 517 nm to light yellow in the presence of antioxidants forming a stable DPPH molecule. [33] MEO showed an effective radical scavenging ability by this assay. ABTS is a blue colored chromophore and upon addition of MEO, it is reduced and this reduction process is concentration dependent. E. officinalis is a rich source of Vitamin C, alkaloids, phenolics, flavonoids, and tannins. [12] In agreement to this, our study revealed that the MEO has a high level of radical scavenging capacity as evidenced in both DPPH and ABTS assays. This might be because of more phenolic compounds in MEO, which help in scavenging of radicals in the two studied assays and hence attribute to their higher antioxidant activity. [13, 33] The phosphomolybdate results further confirmed the potent antioxidant activity of MEO, which increased in a concentrationdependent manner.
In vivo toxicological estimation was performed to evaluate the extent to which a drug can cause deleterious effects to the cells; these tests are essential and widely accepted to know the optimum drug concentration to be administered. LD of MEO was measured to check lethal toxicity and was found to be 1125 mg/kg BW. Treatment with MEO at a dose of 200mg/kg and 400mg/kg to their respective group of mice for 1 month did 50 50 not show any toxic side effect. The selection of the 2 doses 200 mg/kg and 400 mg/kg was based on an initial toxicity study where until 1 month after administration of these doses of the extract, the animals were healthy without any visual signs or symptoms of illness (data not shown). Previously, Golechha et al., 2014[34] showed that a 300-500 mg/kg dose of Emblica has not shown any adverse effect.
Carrageenan induced edema of rat paw is used widely as a working model of acute inflammation in search for new anti inflammatory drugs. [35] During the first 2 h (Phase I), liberation of histamine and serotonin begins in rat paw after carrageenan injection, whereas in Phase II release of kinin, prostaglandin, bradykinin, leukotrienes, and polymorphonuclear cells in the damaged tissue in surroundings cells also increases depending upon the complement system for their activation. [34] Results of standard drug diclofenac sodium, normal saline, and two doses of test extracts (LMEO and HMEO) were compared. Both the tested doses of MEO have shown a significant reduction in paw volume as compared to control group; the efficiency of MEO is very much comparable to that of the standard drug (P < 0.05).
Our in vivo results were strongly in accordance to previous studies. [36] In case of infection, inflammation, and immune activation, IL1β and TNFα play a major role. Sometimes, TNFα can also stimulate the release of IL1β. [4] The levels of IL1β and TNFα of experimental animals showed a significant decrease after administration of MEO as compared to the salinetreated animal group. Rats treated with high dosage (400 mg/ml) showed more potent effect than lower dosage (200 mg/ml) which is very much comparable to the standard drug.
The role of phenolic compounds in inflammatory conditions is well established. [37, 38] They also inhibit polymorphonuclear lipoxygenase, an enzyme involved in inflammatory conditions. [37] In this context, E. officinalis has caught the attention of the researchers as it is a potential source of phenolic compounds and flavonoids. [36] These effects may be due to high levels of quercetin, rutin, and other phenolic compounds found in the MEO. [23, 28] 
CONCLUSIONS
In summary, the results of this study suggest that MEO not only is a storehouse of natural antioxidant but also possesses strong antiinflammatory activity which might be helpful in preventing or slowing the progress of various oxidative stressrelated diseases. The antiinflammatory activity of MEO may probably be due to the presence of several bioactive antiinflammatory principals as elucidated by HPLC analysis. However, it needs isolation, structural elucidation, and screening of any of the various active principle (s) to point out the real activity of the drug. Even, an extensive clinical study needs to be hypothesized to ascertain the efficacy and safety of this agent to illustrate an improvement over currently available treatment.
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